Question

A 62-year-old man with T2DM and established ASCVD (prior NSTEMI) has A1C 7.3% on metformin. eGFR 58 mL/min/1.73 m², UACR 110 mg/g. Which addition is most appropriate to reduce cardiorenal risk?

Accepted Answer

Add a GLP-1 receptor agonist with cardiovascular benefit

Answer

Add basal insulin

Answer

Add a DPP-4 inhibitor

Answer

Switch to sulfonylurea

Answer

No change needed until A1C >=8%

Practice question

A 62-year-old man with T2DM and established ASCVD (prior NSTEMI) has A1C 7.3% on metformin. eGFR 58 mL/min/1.73 m², UACR 110 mg/g. Which addition is most appropriate to reduce cardiorenal risk?